Have a personal or library account? Click to login
Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19 Cover

Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19

Open Access
|Nov 2021

References

  1. 1. WORLD HEALTH ORGANIZATION. 2020. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. Geneva (Switzerland): WHO; 2020 [cited 2020 May 21]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.
  2. 2. XU Z., SHI L., WANG Y., ZHANG J., HUANG L., ZHANG C., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Resp Med. 2020;8(4):420–22.10.1016/S2213-2600(20)30076-X
  3. 3. WANG D., HU B., HU C., ZHU F., LIU X., ZHANG J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–69.10.1001/jama.2020.1585704288132031570
  4. 4. ZHENG F., LIAO C., FAN QH., CHEN HB., ZHAO XG., XIE ZG., et al. Clinical characteristics of coronavirus disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–80.10.1007/s11596-020-2172-6709506532207032
  5. 5. AVANOGLU GULER A., TOMBUL N., AYSERT YILDIZ P., SELÇUK ÖZGER H., HIZEL K., GULBAHAR O. The assessment of serum ACE activity in COVID-19 and its association with clinical features andseverity of the disease. Scand J Clin Lab Invest. 2021;21:1–6.
  6. 6. RICHARDSON S., HIRSCH JS., NARASIMHAN M., CRAWFORD M., MCGINN T., DAVIDSON K., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052–59.10.1001/jama.2020.6775717762932320003
  7. 7. ZHENG Z., PENG F., XU B., ZHAO J., LIU H., PENG J., et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. 2020;81(2):e16–e25.10.1016/j.jinf.2020.04.021717709832335169
  8. 8. FU L., WANG B., YUAN T., CHEN X., AO Y., FITZPATRICK T., et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect. 2020;80(6):656–65.10.1016/j.jinf.2020.03.041715141632283155
  9. 9. HARRISON AG., LIN T., WANG P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020;41(12):1100–15.10.1016/j.it.2020.10.004755677933132005
  10. 10. SEYED HOSSEINI E., RIAHI KASHANI N., NIKZAD H., AZADBAKHT J., HASSANI BAFRANI H., HADDAD KASHANI H. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology. 2020;551:1–9.10.1016/j.virol.2020.08.011751380233010669
  11. 11. MAIUOLO J., MOLLACE R., GLIOZZI M., MUSOLINO V., CARRESI C., PAONE S., SCICCHITANO M., et al. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection. Int J Mol Sci. 2020;21(23):9309.10.3390/ijms21239309773035233291346
  12. 12. CECCHINI R., CECCHINI AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses. 2020;143:110102.10.1016/j.mehy.2020.110102735749832721799
  13. 13. IDDIR M., BRITO A., DINGEO G., FERNANDEZ DEL CAMPO S., SAMOUDA H., LA FRANO MR., et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients. 2020;12(6):1562.10.3390/nu12061562
  14. 14. SUHAIL S., ZAJAC J., FOSSUM C., LOWATER H., MCCRACKEN C., SEVERSON N., et al. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review. The Protein Journal. 2020;39:644–56.10.1007/s10930-020-09935-8
  15. 15. MIRONOVA GD., BELOSLUDTSEVA NV., ANANYAN MA. Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications. Eur Rev Med Pharmacol Sci. 2020;16:8585–91.
  16. 16. BELTRAN-GARCIA J., OSCA-VERDEGAL R., PALLARDO FV., FERRERES J., RODRIGUEZ M., MULET S., et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants (Basel). 2020;9(10):936.10.3390/antiox9100936
  17. 17. DELGADO-ROCHE L., MESTA F. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection. Arch Med Res. 2020;51(5):384–87.10.1016/j.arcmed.2020.04.019
  18. 18. SCHWARZ KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641–9.10.1016/0891-5849(96)00131-1
  19. 19. ZAFAR PARACHA U., FATIMA K., ALQAHTANI M., CHAUDHARY A., ABUZENADAH A., DAMANHOURI G., et al. Oxidative stress and hepatitis C virus. Virol J. 2013;10:251.10.1186/1743-422X-10-251375157623923986
  20. 20. HOSAKOTE Y., LIU T., CASTRO SM., GAROFALO RP., CASOLA A. Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes. Am J Respir Cell Mol Biol. 2009;41(3):348–57.10.1165/rcmb.2008-0330OC274275419151318
  21. 21. KHOMICH OA., KOCHETKOV SN., BARTOSCH B., IVANOV AV. Redox Biology of Respiratory Viral Infections. Viruses. 2018;10(8):392.10.3390/v10080392611577630049972
  22. 22. CHECCONI P., DE ANGELIS M., MARCOCCI ME., FRATERNALE A., MAGNANI M., PALAMARA AT., et al. Redox-Modulating Agents in the Treatment of Viral Infections. Int J Mol Sci. 2020;21(11):4084.10.3390/ijms21114084731289832521619
  23. 23. CAMINI FC., DA SILVA CAETANO CC., ALMEIDA LT., DE BRITO MAGALHÃES CL. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017;162(4):907–17.10.1007/s00705-016-3187-y28039563
  24. 24. ALAMDARI DH., MOGHADDAM AB., AMINI S., KERAMATI MR., ZARMEHRI AM., ALAMDARI AH., et al. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur J Pharmacol. 2020;885:173494.10.1016/j.ejphar.2020.173494744015932828741
  25. 25. ZHANG R., WANG X., NI L., DI X., MA B., NIU S., et al. COVID-19: Melatonin as potential adjuvant treatment. Life Sci. 2020;250:117583.10.1016/j.lfs.2020.117583710258332217117
  26. 26. CUADRADO A., PAJARES M., BENITO C., JIMENEZ-VILLEGAS J., ESCOLL M., FERNANDEZ-GINES., et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020; 41(9):598–610.10.1016/j.tips.2020.07.003735980832711925
  27. 27. DE LAS HERAS N., MARTÍN GIMÉNEZ VM., FERDER L., MANUCHA W., LAHERA V. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D. Antioxidants (Basel). 2020;9(9):897.10.3390/antiox9090897755573132967329
  28. 28. CARRATELLI M., IORIO EL., BIANCHI L. Methods to measure the oxidative stress. ADI Magazine. 2006;4(10):405–14.
  29. 29. ALBERTI A., BOLOGNINI L., MACCIANTELLI D., CARATELLI M. The radical cation of N,N-diethyl-paraphenylendiamine: A possible indicator of oxidative stress in biological samples. Res Chem Interm. 2000;26:253–67.10.1163/156856700X00769
  30. 30. GADOTTI AC., LIPINSKI AL., VASCONCELLOS FT., MARQUEZE LF., CUNHA EB., CAMPOS AC., et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med. 2021;165:184–190.10.1016/j.freeradbiomed.2021.01.044784646033524532
  31. 31. MUHAMMAD Y., AMINU KANI Y., ILIYA S., BUNZA MUHAMMAD J., BINJI A., EL-FULATY AHMAD A., et al. Deficiency of antioxidants and increased oxidative stress in COVID-19 patients: A cross sectional comparative study in Jigawa, Northwestern Nigeria. SAGE Open Med. 2021;9:1–8.10.1177/2050312121991246787128233614035
  32. 32. PINCEMAIL J., CAVALIER E., CHARLIER C., CHERAMY-BIEN JP., BREVERS E., AUDREY COURTOIS A. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants (Basel). 2021;10(2):257.10.3390/antiox10020257791460333562403
  33. 33. POLONIKOV A. Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients. ACS Infect Dis. 2020;6(7):1558–62.10.1021/acsinfecdis.0c00288726307732463221
DOI: https://doi.org/10.2478/rjim-2021-0014 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Language: English
Page range: 375 - 383
Submitted on: Mar 29, 2021
|
Published on: Nov 20, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Dragica Zendelovska, Emilija Atanasovska, Marija Petrushevska, Katerina Spasovska, Milena Stevanovikj, Ilir Demiri, Nikola Labachevski, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.